Bloggingstocks.com Ore 16.00 Closing Bell Enzon Pharmaceuticals
Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) rose on a $300 million-plus sale of four of its
pharmaceutical products to Sigma-Tau Pharmaceuticals. Shares were up almost 7% at $9.60
right before the close.
Ritaglio stampa ad uso esclusivo del destinatario, non riproducibile